BlueRock Therapeutics società ha sostenuto
BlueRock Therapeutics LP is a clinical stage cell therapy harnessing the power of cell therapy to create a pipeline of new medicines for people suffering from neurological and ophthalmic diseases. Two of our novel investigational cell therapies, bemdaneprocel (BRT-DA01) for the treatment of Parkinson’s disease and OpCT-001 for the treatment of primary photoreceptor diseases are clinical stage programs. BlueRock was founded in 2016 as a joint venture of Versant Ventures and Leaps by Bayer. Our culture is defined by the courage to persist regardless of the challenge, the urgency to transform medicine and deliver hope, integrity guided by mission, and community-mindedness with the understanding that we are all part of something bigger than ourselves.
leggi di più
BlueRock has an incredible pool of talented, driven and friendly employees, which makes working here challenging and satisfying. Navigating the Bayer relationship adds complexities, but seems to be manageable so far.
Qual è la parte migliore del tuo compenso?
Nothing stands out, but it is competitive with industry norms.
Che cosa ti rende più felice sul posto di lavoro?
Interacting with such talented colleagues and learning something new every day.
Quali sono alcune delle cose migliori della tuo team?
Passion for the work and respect for others; willingness to learn constantly.
La cosa più positiva della cultura e l'ambiente presso la tua azienda?
The commitment to hire not just incredible talent and SMEs, but also the right personality.
Cosa ti piace di più del team di leadership?
Ability to listen and truly consider what they heard; focus, energy, drive, yet still with an eye on a good corporate culture.
Other Employee Reviews for BlueRock Therapeutics
×